147 related articles for article (PubMed ID: 29748959)
1. Changes in intestinal microbiota affect metabolism of ginsenoside Re.
Zhang L; Li F; Qin WJ; Fu C; Zhang XL
Biomed Chromatogr; 2018 Oct; 32(10):e4284. PubMed ID: 29748959
[TBL] [Abstract][Full Text] [Related]
2. Qualitatively and quantitatively investigating the regulation of intestinal microbiota on the metabolism of panax notoginseng saponins.
Xiao J; Chen H; Kang D; Shao Y; Shen B; Li X; Yin X; Zhu Z; Li H; Rao T; Xie L; Wang G; Liang Y
J Ethnopharmacol; 2016 Dec; 194():324-336. PubMed ID: 27637802
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of the Rats' Gut Microbiota Composition in Animals with Different Ginsenosides Metabolizing Activity.
Dong WW; Xuan FL; Zhong FL; Jiang J; Wu S; Li D; Quan LH
J Agric Food Chem; 2017 Jan; 65(2):327-337. PubMed ID: 28025886
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of antidiabetic and synergistic effects of ginseng polysaccharide and ginsenoside Rb1 on diabetic rat model.
Li J; Li R; Li N; Zheng F; Dai Y; Ge Y; Yue H; Yu S
J Pharm Biomed Anal; 2018 Sep; 158():451-460. PubMed ID: 30032757
[TBL] [Abstract][Full Text] [Related]
5. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Panax notoginseng saponins metabolites in rat plasma with in vivo gut microbiota-mediated biotransformation by HPLC-MS/MS.
Guo YP; Chen MY; Shao L; Zhang W; Rao T; Zhou HH; Huang WH
Chin J Nat Med; 2019 Mar; 17(3):231-240. PubMed ID: 30910060
[TBL] [Abstract][Full Text] [Related]
7. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
Xu R; Peng Y; Wang M; Fan L; Li X
J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: Contrary effects of antimicrobials treatment and restraint stress.
Kang A; Zhang S; Zhu D; Dong Y; Shan J; Xie T; Wen H; Di L
Chem Biol Interact; 2016 Oct; 258():187-96. PubMed ID: 27613481
[TBL] [Abstract][Full Text] [Related]
9. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic study of ginsenoside Re in rats].
Chen G; Yang M; Guo D
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1540-3. PubMed ID: 19777842
[TBL] [Abstract][Full Text] [Related]
11. Differences in Intestinal Metabolism of Ginseng Between Normal and Immunosuppressed Rats.
Zhu JH; Xu JD; Zhou SS; Zhang XY; Zhou J; Kong M; Mao Q; Zhu H; Li SL
Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):93-104. PubMed ID: 32894450
[TBL] [Abstract][Full Text] [Related]
12. Metabolic analysis of Panax notoginseng saponins with gut microbiota-mediated biotransformation by HPLC-DAD-Q-TOF-MS/MS.
Chen MY; Shao L; Zhang W; Wang CZ; Zhou HH; Huang WH; Yuan CS
J Pharm Biomed Anal; 2018 Feb; 150():199-207. PubMed ID: 29245089
[TBL] [Abstract][Full Text] [Related]
13. Metabolic characteristics of ginsenosides from Panax ginseng in rat feces mediated by gut microbiota.
Wang L; Shao L; Huang ST; Liu Z; Zhang W; Hu K; Huang WH
J Pharm Biomed Anal; 2024 Jan; 237():115786. PubMed ID: 37837893
[TBL] [Abstract][Full Text] [Related]
14. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
[No Abstract] [Full Text] [Related]
15. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry.
Wan JY; Liu P; Wang HY; Qi LW; Wang CZ; Li P; Yuan CS
J Chromatogr A; 2013 Apr; 1286():83-92. PubMed ID: 23499252
[TBL] [Abstract][Full Text] [Related]
16. In vitro biotransformation of red ginseng extract by human intestinal microflora: metabolites identification and metabolic profile elucidation using LC-Q-TOF/MS.
Wang HY; Hua HY; Liu XY; Liu JH; Yu BY
J Pharm Biomed Anal; 2014 Sep; 98():296-306. PubMed ID: 24973593
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 mitigates morphine dependence via regulation of gut microbiota, tryptophan metabolism, and serotonergic system function.
Chen Z; Lin Y; Zhou Q; Xiao S; Li C; Lin R; Li J; Chen Y; Luo C; Mo Z
Biomed Pharmacother; 2022 Jun; 150():112935. PubMed ID: 35447543
[TBL] [Abstract][Full Text] [Related]
18. Identification and quantitative investigation of the effects of intestinal microflora on the metabolism and pharmacokinetics of notoginsenoside Fc assayed by liquid chromatography with electrospray ionization tandem mass spectrometry.
Ju Z; Li J; Lu Q; Yang Y; Yang L; Wang Z
J Sep Sci; 2019 May; 42(9):1740-1749. PubMed ID: 30805999
[TBL] [Abstract][Full Text] [Related]
19. Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota.
Zhang X; Chen S; Duan F; Liu A; Li S; Zhong W; Sheng W; Chen J; Xu J; Xiao S
J Ginseng Res; 2021 Mar; 45(2):334-343. PubMed ID: 33841014
[TBL] [Abstract][Full Text] [Related]
20. Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species.
Zhang Y; Yao L; Tang C; Jiang J; Ye Y; Liu J
Biomed Chromatogr; 2021 Dec; 35(12):e5219. PubMed ID: 34327712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
